V. V. Filonenko
Ludwig Institute for Cancer Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by V. V. Filonenko.
The EMBO Journal | 2000
Ivan Gout; Gayle Middleton; Jimi Adu; Natalia Ninkina; Ludmila B. Drobot; V. V. Filonenko; Gennady Matsuka; Alun M. Davies; Michael D. Waterfield; Vladimir L. Buchman
Class IA phosphatidylinositol 3‐kinase (PI 3‐kinase) is a key component of important intracellular signalling cascades. We have identified an adaptor protein, Rukl, which forms complexes with the PI 3‐kinase holoenzyme in vitro and in vivo. This interaction involves the proline‐rich region of Ruk and the SH3 domain of the p85α regulatory subunit of the class IA PI 3‐kinase. In contrast to many other adaptor proteins that activate PI 3‐kinase, interaction with Rukl substantially inhibits the lipid kinase activity of the enzyme. Overexpression of Rukl in cultured primary neurons induces apoptosis, an effect that could be reversed by co‐expression of constitutively activated forms of the p110α catalytic subunit of PI 3‐kinase or its downstream effector PKB/Akt. Our data provide evidence for the existence of a negative regulator of the PI 3‐kinase signalling pathway that is essential for maintaining cellular homeostasis. Structural similarities between Ruk, CIN85 and CD2AP/CMS suggest that these proteins form a novel family of adaptor molecules that are involved in various intracellular signalling pathways.
Journal of Biological Chemistry | 1998
Ivan Gout; Taichi Minami; Kenta Hara; Yosuke Tsujishita; V. V. Filonenko; Michael D. Waterfield; Kazuyoshi Yonezawa
A novel ribosomal S6 kinase, termed p70 S6 kinase β (p70β), which has a highly conserved amino acid sequence compared with that of p70/p85 S6 kinase (p70α) within the catalytic, kinase extension, and autoinhibitory pseudosubstrate domains, was identified. However, the amino acid sequence of p70β differs from that of p70α in the noncatalytic amino-terminal region and in the carboxyl-terminal tail, which contains a proline-rich region. The majority of the regulatory phosphorylation sites identified in p70α are conserved in p70β. Two isoforms of p70β, referred to as β1 (495 amino acids) and β2 (482 amino acids), could be expressed from the single gene either by alternative mRNA splicing or by the use of alternative start codons. Here we report the characterization of p70β2. Similarly to p70α, the catalytic activity of p70β toward ribosomal protein S6 could be rapidly activated by serum, insulin, and phorbol ester in transiently transfected cells. The p70β kinase was found to be significantly less sensitive to wortmannin and rapamycin than p70α. These results indicate that p70β has the potential to participate in the regulation of protein synthesis and the cell cycle.
Leukemia Research | 2006
Rodrigo Proto-Siqueira; Lorena Lobo de Figueiredo-Pontes; Rodrigo A. Panepucci; Aglair B. Garcia; Edgar G. Rizzatti; Fabio M. Nascimento; Hellen C.F. Ishikawa; Roy E. Larson; Roberto P. Falcao; Andrew J.G. Simpson; Ivan Gout; V. V. Filonenko; Eduardo M. Rego; Marco A. Zago
Archive | 2000
Ivan Gout; Nikolay Rodnin; V. V. Filonenko; Genadiy Matsuka; Matthew J. Scanlan; Lloyd Old; Boris Bilynsky
Biopolymers & Cell | 2010
D. O. Gudkova; Ganna Panasyuk; Ivan Nemazanyy; V. V. Filonenko
Biopolymers & Cell | 2009
O. S. Breus; Ivan Nemazanyy; Ivan Gout; V. V. Filonenko; Ganna Panasyuk
Biopolymers & Cell | 2005
Ganna Panasyuk; I. O. Nemzanyy; A. M. Zhyvoloup; V. V. Filonenko; Ivan Gout
Biopolymers & Cell | 2007
O. M. Malanchuk; S. S. Palchevskyy; V. K. Pozur; Ivan Gout; V. V. Filonenko
Biopolymers & Cell | 2000
M. V. Rodnin; I. O. Tykhonkova; V. V. Filonenko; Ludmila B. Drobot; G. Kh. Matsuka; Ivan Gout
Biopolymers & Cell | 2000
L. L. Sidorik; T. A. Rybkinska; N. G. Bakhiya; N. V. Rodnin; V. V. Filonenko; N. S. Entelis; I. A. Tarassov; R. P. Martin; G. Kh. Matsuka